Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSC | P53634 | 1/20 | 0.76 |
| ▸ | SPR | P35270 | 4/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | IDO1 | P14902 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.61 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.61 |
| ▸ | TRPV1 | Q8NER1 | 9/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.56 |
| ▸ | FAAH | O00519 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1132501 | 0.86 | CTSC (1.00) | CTSCKDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL1132068 | 0.86 | CTSC (1.00) | CTSCKDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL7706652 | 0.85 | SPR (0.68) | SPRKDM4EALDH1A1NPSR1CYP2D6 | |
| SCHEMBL24277478 | 0.85 | SPR (0.74) | SPRKDM4EALDH1A1NPSR1CYP2D6 | |
| SCHEMBL20168578 | 0.85 | HDAC8 (0.77) | SPRKDM4EALDH1A1NPSR1CYP2D6 | |
| SCHEMBL6399249 | 0.85 | SPR (0.74) | SPRKDM4EALDH1A1NPSR1CYP2D6 | |
| SCHEMBL20168582 | 0.85 | HDAC8 (0.77) | SPRKDM4EALDH1A1NPSR1CYP2D6 | |
| SCHEMBL29804259 | 0.85 | HDAC8 (0.77) | SPRKDM4EALDH1A1NPSR1CYP2D6 | |
| SCHEMBL15145420 | 0.84 | SPR (0.77) | SPRKDM4EALDH1A1NPSR1CYP2D6 | |
| SCHEMBL12720784 | 0.82 | SPR (1.00) | SPRKDM4EALDH1A1NPSR1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1408032-B1 | Coupling product between tryptamine and an alpha-amino acid and its use in the field of neuro-cosmetics | EXSYMOL SA (MC) | 2011-02-16 | — | — | EP | disclosed |
| US-7094796-B2 | Coupling product between tryptamine and an alpha-amino acid, process for its preparation as well as its application in the neurocosmetic field | EXSYMOL S.A.M. (MC) | 2006-08-22 | — | — | US | disclosed |
| US-20040110814-A1 | Coupling product between tryptamine and an alpha-amino acid, process for its preparation as well as its application in the neurocosmetic field | EXSYLMOL S.A.M. | 2004-06-10 | — | — | US | disclosed |
| EP-1408032-A2 | Coupling product between tryptamine and an alpha-amino acid and its use in the field of neuro-cosmetics | EXSYMOL S.A.M. (MC) | 2004-04-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110814-A1 | Coupling product between tryptamine and an alpha-amino acid, process for its preparation as well as its application in the neurocosmetic field | TPH1, IDO1, KYNU | CTSC 1123/4885SPR 519/4885KDM4E 4594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.